24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We are just about to enter into an earnings season in which most major companies will report and set a direction for the market. We have included the consensus earnings estimates from Thomson Reuters and the stock price and trading history, as well as added some additional color on each.

Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some companies may change reporting dates as well.

Walgreens Boots Alliance

Walgreens Boots Alliance Inc. (NASDAQ: WBA) is set to report its fiscal second-quarter results before Tuesday’s opening bell. The analysts’ consensus estimates call for earnings per share (EPS) of $1.28 and $30.66 billion in revenue. In the previous quarter, the drug store operator exceeded the consensus earnings forecast, yet it fell short on the top line. Yet Walgreens increased the low end of its fiscal-year adjusted EPS guidance by five cents to a new range of $4.30 to $4.55. That guidance assumed no material help from the proposed acquisition of Rite Aid, which was expected to close in the second half of 2016.

Shares were changing hands at $86.70 as Friday’s trading came to a close. The consensus price target is $94.14, and the stock has a 52-week trading range of $71.50 to $97.30.

Bed Bath & Beyond

Bed Bath & Beyond Inc. (NASDAQ: BBBY) is scheduled to report its fiscal fourth-quarter results on Wednesday. The consensus estimates call for $1.81 in EPS, as well as $3.38 billion in revenue. In its most recent earnings report, the company gave guidance for its fourth quarter. The company expects comparable sales for the quarter to be either flat or increase by 2%. At the same time, the company expects EPS to be in the range of $1.72 to $1.86.

Shares were trading at $49.51 on Friday’s close. The consensus price target is $48.17. The stock has a 52-week trading range of $41.26 to $78.10.

Rite Aid

Rite Aid Corp. (NYSE: RAD) is scheduled to report its fiscal fourth-quarter results on Thursday. The consensus analyst estimates call for $0.06 in EPS and revenue of $8.40 billion. This company remains caught in what many investors equate to a merger time warp. That often just might not mean that the low volatility in a post-merger announcement leaves any great value or upside in the turnaround pharmacy chain. In the case of Rite Aid, it could be the opposite.

Shares of Rite Aid ended last week at $8.19. The consensus analyst price target is $9.00. The 52-week trading range is $5.88 to $9.47.

CarMax

CarMax Inc. (NYSE: KMX) is set to share its latest quarterly earnings on Thursday. The consensus estimates call for $0.71 in EPS and $3.68 billion in revenue. Oppenheimer recently lifted its rating on CarMax to Outperform and establishing a $60 target price for the shares. For a long while, the firm has looked at this company as one of the most promising new unit growth and market share stories in retail.

Shares were at $51.75 on Friday’s close, in a 52-week range of $41.25 to $75.40. The stock has a consensus price target of $62.35.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.